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This paper is the second in a series of reviews of cross-cultural studies of menopausal 
symptoms. The goal of this review is to compare and contrast methods which have been 
previously utilized in cross-cultural midlife women’s health studies with a view to (1) 
identifying the challenges in measurement across cultures in psychological symptoms and (2) 
suggesting a set of unified questions and tools that can be used in future research in this area. 
This review also aims to examine the determinants of psychological symptoms and how those 
determinants were measured. The review included eight studies that explicitly compared 
symptoms in different countries or different ethnic groups in the same country and included: 
Australian/Japanese Midlife Women’s Health Study (AJMWHS), Decisions At Menopause 
Study (DAMeS), Four Major Ethnic Groups (FMEG), Hilo Women's Health Survey 
(HWHS),Penn Ovarian Aging Study (POAS), Study of Women's Health Across the Nation 
(SWAN), Women’s Health in Midlife National Study (WHiMNS), and the Women’s 
International Study of Health and Sexuality (WISHeS) and.  
 
This review concludes that mental morbidity does affect vasomotor symptom prevalence 
across cultures and therefore should be measured. Based on the review of these eight studies 
it is recommended that the following items be included when measuring psychological 
symptoms across cultures, feeling tense or nervous, sleeping difficulty, difficulty in 
concentrating, depressed and irritability along with the CES-D scale, and the Perceived 
Stress Scale. The measurement of these symptoms will provide an evidence based approach 


















2. Methodological considerations 
3. Results 
3.1. Measures of psychological symptom frequencies 




Cross-national epidemiological surveys of depression suggest that females have 
approximately double the lifetime rates of males (1). This sex difference begins in 
adolescence, increases during the reproductive years and is largest in middle age, peaking 
before menopause for women (2). Literature ranges from assertions that psychological 
symptoms increase across the menopausal transition, to menopausal depression is more 
highly correlated with previous depression, to more complex biopsychosocial etiological 
models (3). Because views of menopause as a risk factor for psychopathology often derive 
from clinical studies, data on psychological symptoms in general populations are needed. 
 
Large cross-cultural studies have provided detailed information about the prevalence of 
menopausal symptoms and have enabled variables from previous studies to be examined as 
predictors of psychological menopausal symptoms. It is difficult, however, to ascertain 
whether life circumstances or the menopausal transition is associated with psychological 
symptoms at midlife (4). In Thailand, - feelings of depression or sadness increased from 
26.19% among pre-menopausal women to a peak of 58.88% among peri-menopausal women 
and then dropping to 43.10% among post-menopausal women (5). 
 
Differences in psychological symptoms across cultures may result from different instruments 
used to measure symptoms across different studies. Psychological symptoms have been 
explored in varying ways with different results. The following review identifies how 
psychological symptoms have been measured across cultures, and suggests a set of unified 
questions and tools that can be used to further cross cultural research in psychological 
symptoms at midlife.  
 
2. Methodological Considerations 
 
The studies included in this review are described in an overview article (6). 
 
Here, determinants of psychological symptoms are presented (Table 1), with attention paid to 
the measurement of these determinants. Bivariate results and the significance of 
country/ethnic differences in relation to psychological symptoms by each of the studies are 
presented in Table 2, with multivariate results shown in Table 3. Recommendations for a set 
of questions and tools are made in the conclusion that can be used in future research in the 




3.1  Measures of psychological symptom frequencies 
 
Symptom checklists used to assess frequencies of psychological symptoms 
 
The measures used for psychological symptoms in the eight studies identified above were all 
subjective measures (self report). Several specific menopausal symptom scales have been 
used, including The Greene Climacteric Scale, several versions of the Everyday Complaint 
Checklist, the Menopause Rating Scale, the Women’s Health Questionnaire, the Kupperman 
Menopausal Index and the Menopause-Specific Quality of Life Questionnaire. Other self 
report scales which have been used to measure psychological symptoms include: the CES-D 
Scale to measure depression, the Zung Anxiety Scale to measure anxiety, and The Perceived 
Stress Scale to measure current stress. 
 
[INSERT TABLE 1 HERE] 
 
The Greene Climacteric Scale (7) was used in the AJMWHS (8-10). The Greene Climacteric 
Scale has strong psychometric properties, including: reliability of the psychological scale 
0.87; content validity; and construct validity which have been confirmed in relation to 
psychological treatment.  
 
This scale measures the extent to which an individual is affected by 21 symptoms for the 
present time. A psychological factor score can be computed from the Greene Climacteric 
Scale. Symptom reports, recoded as yes/no, and psychological factor scores are compared in 
Table 1. For comparison across studies, scores in Table 2 represent women who indicated any 
symptom experience. Calculation of a Psychological Scale is the sum of symptoms 1-11 
(recorded above). The psychological scale can be further subdivided to give measures of: 
Anxiety – sum of items 1-6, and Depression- sum of 7-11. 
The Everyday Complaint Checklist (11, 12) was used as the base for the symptom list in 
DAMeS (13), HWHS (14), and SWAN (15). Percentages in Table 2 reflect the number of 
women who said they had experienced the symptom, regardless of frequency (e.g., regular or 
occasional). In DAMeS, the scale includes a symptom checklist consisting of 25 items, and 
covers a variety of manifestations for psychological symptoms.  
The Hilo Women’s Health survey used a modified version of the Everyday Complaint 
Checklist with the items related to psychological symptoms. The Everyday Complaint 
Checklist was modified and used as the base for the 12 item symptom list used in SWAN. 
The list was tested in focus groups of European, African, Japanese, Chinese, and Hispanic 
women (15). Sleep was measured with one item asking about the quality of a typical night’s 
sleep in the past two weeks (very sound/ sound/ average or restless/ very restless) taken from 
the Women’s Health Initiative. Further psychosocial scales included 1) the Center for 
Epidemiological Studies (CES-D) scale (16), with a cut point for depression of 16 or above; 
and 2) the perceived stress scale.  
 
The FMEG used the Midlife Women’s Symptom Index to measure 73 symptoms, including 
psychological symptoms.  
 
The Women’s Health Questionnaire (WHQ) (17) was used in the MAHWIS (18) to measure 
depressed mood and anxiety. The WHQ is a 36-item questionnaire developed to assess nine 
areas of current (past 2 weeks) symptom experience in middle-aged women. It has good 
psychometric properties including high internal reliability (Cronbach’s alpha 0.7-0.84 and 
high test-retest reliability: 0.78-0.96). Provisional multi-trait analysis suggests that the 
internal reliability of the subscales is reasonable. Cronbach alpha levels were as follows: 
depressed mood (.7), anxiety (.77), sleep problems (.73); depression and anxiety subscales. 
The psychological symptoms measured are scored on a four point scale from “yes definitely” 
to “no, not much at all” (19).  
 
The Penn Ovarian Aging Study (POAS) used the Kupperman Menopausal Index to develop a 
Menopause Symptom List (MSL) (20). Each of the study symptoms was queried using the 
validated symptom list that was embedded in the structured interview questionnaire. The 
psychological symptoms questioned included: depressed mood and poor sleep. A sleep 
quality factor score derived from St Mary’s Hospital Sleep questionnaire, was adapted for the 
population. Participants were asked if 12 symptoms occurred in the past month, the frequency 
of each symptoms, and severity (0 none to 3 severe), (20); however, in published study 
results, frequencies are not given for each symptom. Trouble sleeping loaded onto a 
Psychological Factor. 
 
In addition to the MSL, a daily symptom rating (DSR) form included 20 common 
menopausal complaints, rated from 0 (not present) to 4 (very severe) (symptoms listed in 
Appendix 1) (21)). The following psychological symptoms were included: anxiety, tension, 
“on edge”, “nerves”; irritability, persistent anger; depression, feeling sad, down or blue; 
insomnia, (trouble sleeping); difficulty concentrating. The DSR was completed each day for 
one menstrual cycle (n=308). DSR scores were calculated by summing item ratings for 
follicular days (6–12) and late luteal days (23–28)(21). The reliability of the DSR was 
estimated at 0.94 for Cronbach’s coefficient alpha.  
 
Depression, anxiety and stress were also measured using the following scales. The CES-D 
Scale assessed current depressive symptoms. Subjects rated 20 items that relate to depressed 
mood from 0 (not at all) to 4 (most of the time); the ratings were summed for a total score. 
Scores greater than 16 were classified as indicating depression (22). The Zung Anxiety Scale 
assessed current anxiety. Subjects rated 5 affective and 15 somatic symptoms on a four-point 
scale ranging from none (0) to all of the time (4). The ratings were summed for a total score, 
with higher scores signifying more anxiety. The CES-D Scale and the Zung Anxiety Scale 
are both well established validated measures of depression and anxiety. The Perceived Stress 
Scale was also used to measure psychological symptoms and is a 14-item validated measure 
to assess current stress. Subjects rated the items on a five-point scale from 0 (never) to 4 
(very often).  
 
The WHiMNS study used a symptom questionnaire derived and modified from two 
questionnaires: the Revised Illness Perception Questionnaire (IPQ-R) (23) and a menopause 
specific quality of life questionnaire (24). Depression symptoms were measured by a short 
form of the CES-D depression symptoms index (25). 
 
The WISHeS study used the Menopause-Specific Quality of Life Questionnaire. This was 
developed as a self-administered instrument to measure the impact of menopausal symptoms 
on quality of life of middle aged women. The questionnaire includes 7 psychosocial items. 
The questionnaire asks each respondent whether she had experienced the symptom in the 
previous month and to indicate how bothered she was by the symptoms on a 7-point Likert 
scale. The investigators of WISHeS added seven symptoms to the original 29 items of the 
scale.  
 
3.2 Determinants of psychological symptoms across studies 
 
Table 2 presents the frequencies of the various psychological symptoms and the significance 
of country/ethnic differences in relation to the psychological symptoms studied.  
 
[INSERT TABLE 2 AND 3 HERE] 
 
In the area of individual symptoms measured with the scales mentioned previously, difficulty 
in sleeping and feeling tired or lacking in energy were found to be statistically different 
amongst the different cultures; Beirut/Rabat/Madrid/Massachusetts (P<0.01) [DAMeS]; Euro 
American/Japanese American (P>0.01) [HWHS]; UK Caucasians/UK Asians/Deli Asians 
(P>0.01)[MAHWIS]; and Jewish/Soviet Immigrants/Arab Israelis (P>0.01) [WHiMNS]; and 
Australian/Japanese women (P<0.01) difficulty in sleeping only [AJMWHS];  
 
In the area of feeling tense or nervous five of the studies measured this symptom with 4 of the 
5 studies revealing statistical differences in the different cultures; Beirut/Rabat 
/Madrid/Massachutess (P<0.01) [DAMeS]; UK Caucasians/UK Asians/Deli Asians 
(P>0.01)[MAHWIS]; and Jewish/Soviet Immigrants/Arab Israelis (P>0.01) [WHiMNS]; 
Australian/Japanese women (P<0.01) [AJMWHS]. 
 
In the area of depression, in all the studies that used the CES-D depression scale score as a 
measure significant differences were seen across cultures; African American/Euro American 
(P>0.01) [POAS]; African American/Hispanic/Chinese/Japanese/European (p>0.01) 
[SWAN]; and Jewish/Soviet Immigrant/Arab Israelis (P>0.01) [WHiMNS].  This finding in 
depression was also supported in 3 out of the 5 studies which asked about feeling 
unhappy/blue or depressed; Beirut/Rabat/Madrid/Massachutess (P<0.01) [DAMeS]; 
Australian/Japanese women (P<0.01); African American /Hispanic /Chinese /Japanese 
/European (P>0.01) [SWAN]. In the AJMWHS between Australian and Japanese women, 
there was also a statistically significant difference in the depression component of the 
psychological factor of the Greene Climacteric Scale (P<0.05). 
 
There were marked differences in prevalence between countries for certain psychological 
symptoms (WISHeS, HWHS). POAS found that African American women when compared 
to white American had increased psychological symptoms severity OR 1.41 (1.02-1.96) 
P=.04. In SWAN feeling tense, depressed and irritable were associated with country/ethnic 
group, age, menopause status, education, ability to pay for basics and self-assessed health. 
There was also a statistically significant ethnic difference in psychological symptoms 
(F=7.10, p<.01) with NH Whites reporting larger numbers of psychological symptoms than 
NH Asians. There was also a statistically significant difference in the total severity of 
psychological symptoms among the four ethnic groups measured including HH Whites, NH 
Asians, Hispanci and NH African Americans (F=7.01, p<.01)(26). 
 
 
4. Discussion  
 
The menopause can be conceptualised at several levels, including hormonal, menstrual, and 
symptomatic.  All of these can lead to different experiences of the menopause. Included in 
this complexity are psychosocial and cultural factors that can also have considerable impact 
on the perceptions and evaluations of women during the menopausal transition. Dennerstein 
et al., found that psychological symptoms declined with age from a maximum prevalence 
before age 40 (27). It has also been found that women who are peri- and post-menopausal 
attributed more psychological symptoms to the menopause than those women who were pre-
menopausal (27). Relationships have been found between psychological symptoms and 
somatic complaints (28); anxiety and hot flushes and previous depression and menopausal 
depression [WISHeS] [POAS]. These findings highlight the importance of including 
psychological, somatic, sexual and vasomotor symptoms in cross cultural studies to 
strengthen the reporting of Menopause and Ageing. 
 
Some interesting cross-cultural studies have not been included in this analysis but are 
important to mention. Firstly The Cross-cultural and intra-cultural comparison in Germany 
and in Papua New Guinea Study (GPNGS) compared women living in Germany with women 
living in Papua New Guinea (29). The authors stated that significant differences between the 
cultures were seen in depression, however, the actual frequencies for the symptoms were not 
provided in the article. In a study across four continents variability existed across women’s 
experience of psychological symptoms with women reporting varying rates of depressive 
mood: Europe 50.7%; USA 55.5%; Latin America 55.6%; and Indonesia 39.6%. Reports of 
anxiety were not significant. The study combined countries into continents, making their 
sample recruitment incomparable across studies, even though they have used the same 
Menopausal Rating Scale (30). Another study conducted by Im et al, 2009, 2010 used a 
cross-sectional Internet survey among 512 midlife women using a convenience sampling 
technique, her findings supported ethnic differences in the number and total severity of 
psychological symptoms; and found that within the U.S., Asian women were found to 
experience the smallest number of psychological symptoms (31, 32).  
 
The psychological items measured by the menopausal scales include the following: feeling 
tense or nervous, difficulty in sleeping, excitable, attack of panic, difficulty in concentrating, 
feeling tired or lacking in energy, loss of interest in most things, feeling unhappy or 
depressed, crying spells, irritability, anxiety, memory loss, mood swings/mood changes, 
forgetfulness, dissatisfied with personal life, wanting to be alone and heart beating quickly or 
strongly. Exploring these further there are several items which were asked in just one or two 
of the eight studies: excitable, attack of panic, loss of interest in most things, forgetfulness, 
dissatisfied with personal life, wanting to be alone and heart beating quickly or strongly, 
crying spells, memory loss and mood swings. Feeling tired or lacking in energy was asked in 
three of the eight studies. The most frequently asked items across all or most of the studies 
included: feeling tense or nervous, difficulty in sleeping, and difficulty in; feeling unhappy or 
depressed (asked very clearly in all the eight studies) and irritability which was asked across 
all the studies (asked as “impatient with other people” in WISHeS and attached to “persistent 
anger” in POAS and “grouchiness” in SWAN). Comparisons of the eight studies and the 
results presented reveal 6 different symptom lists and one Daily Record Score, therefore 
comparisons between the different checklists is difficult. Most of the studies present 
percentage scores for the different symptoms however in some studies, only significant 
differences are recorded or composite total scale scores, these scores then could not be 
compared to results from other studies.  
 
In conclusion, our review reveals that mental morbidity influences other psychological 
symptom prevalence across cultures and therefore should be measured. The seven symptoms 
most linked to menopausal hormonal changes in the WISHeS study may provide an evidence 
based approach when forming any future menopause symptom list. The study, however, 
needs to be replicated with women in each country, including non-western countries, being 
found by more formal population-sampling techniques. There is a need to record actual date 
of final menstrual period and biological data such as hormone levels. 
 
Other scales used to measure psychological symptoms including the CES-D scale, The Zung 
Anxiety scale and the Perceived Stress scale. These scales may be useful tools to include in 
further cross-cultural studies which measure menopausal symptoms as they provide a reliable 
and valid scale score providing a meaningful measurement which could be comparable. It is 
important that future studies consider not combining psychological items (i.e. irritability with 
grouchiness) and state the item to be measured in a clear way, eg: irritability. This will allow 
for comparisons across studies. Reviewing all the eight studies it is recommended that the 
following items be included when measuring psychological symptoms across cultures, along 
with the CES-D scale, and the Perceived Stress Scale;  
 
 Feeling tense or nervous 
 Sleeping difficulty 





In summary it is clinically important that psychological symptoms at midlife are studied. 
Psychological symptoms may considerably impact the quality of life of women and are 
important to review and understand. Psychological symptoms also need to be studied for their 
relationship with other symptoms such as vasomotor, as depression and anxiety have been 
shown to influence rates of vasomotor symptoms (27, 33-37). 
 
 
List of Tables 
Table 1: Measures used to measure psychological symptoms in Cross-Cultural Midlife 
Women's Health Studies 
 
Table 2: Frequencies (yes/no) of various psychological symptoms (%), and mean values for 
psychological factor scores 
 




Contributors and their role 
Paper conception, review, data extraction, drafting of manuscript and preparation of 






Provenance and peer review 
Commissioned and externally peer reviewed. 
 
 
Table 1 Measures used to measure psychological symptoms in Cross-Cultural Midlife Women's Health Studies 
Studies Instruments Questions List symptoms  
Australian/ Japanese Midlife 
Women’s Health Study 
(AJMWHS) (8) 
 
Greene Climacteric Scale 
 
The extent to which you are 
bothered at the moment by 
the following symptoms  
1. Heart beating quickly or strongly; 2. Feeling tense or 
nervous; 3. Difficulty in sleeping; 4. Excitable; 5. Attack of 
panic; 6. Difficulty in concentrating; 7. Feeling tired or 
lacking in energy; 8. Loss of interest in most things; 9. 
Feeling unhappy or depressed; 10. Crying spells; 11. 
Irritability 
 
Decision At Menopause 
Study (DAMeS) (38) 
 
The Everyday Complaint 
Checklist 
 
Whether they had 
experienced symptoms over 
the past month, and whether 
this was occasional or regular 
 
1. Emotional; 2. Anxiety; 3. Depression; 4. Irritability; 5. 
Difficulty concentrating; 6. Memory loss 
 
Four Major Ethnic Groups 
(FMEG) (31) 
 
The Midlife Women’s 
Symptom Index 
 
The presence and severity of 
symptoms during the past 6 
months 
1. Frequent crying; 2. Mood swing; 3. Panicky; 4. 
Difficulty in concentration; 5. Forgetfulness; 6. Feeling 
tense (retrieved from Table 3 (31)) 
 
Hilo Women's Health Survey 
(HWHS) (39) 
 
The Everyday Complaint 
Checklist 
 
Thinking back over the past 
2 weeks, have you ever been 
bothered by any of the 
following symptoms 
1. Trouble sleeping difficulty in concentrating; 2. Feeling 
blue or depressed; 3. Irritability; 4. Mood swings/mood 
changes; 5. Nervous tension 
Mid-Aged Health in Women 
from the Indian Subcontinent 
(MAHWIS) (40) 
 
The Women’s Health 
Questionnaire 
 
How often did you 
experience the following 
symptoms in the past few 
days 
1. Depressed mood (6 items); 2. Anxiety/fears (4 items); 3. 
Sleep problems (3 items); 4. Memory/concentration (3 
items) 
 
Penn Ovarian Aging Study 
(POAS) (21) 
 
The Kupperman Menopausal 
Index (modified version) 
used in a Daily Symptom 
Report 
 
CES-D Scale: Depression 
The Zung Anxiety Scale: 
anxiety 
The Perceived Stress Scale: 
Whether each of the 
symptoms occurred in the 
past month, the frequency 
and severity rated on a four 
point scale from 0 (none) to 3 
(severe).  
1. Anxiety, tension, “onedge”; “nerves” ; 2. Irritability, 
persistent anger; 3. Depression, feeling sad, down or blue; 





St Mary’s Hospital Sleep 
questionnaire 
 
Study of Women's Health 
Across the Nation (SWAN) 
(41) 
 
The Everyday Complaint 
Checklist (modified version) 
 
Center for Epidemiological 
Studies (CES-D) scale 
Perceived stress scale 
 
How frequently they had 
experienced each of the 4 
mood symptoms in the 
previous 2 weeks. 
1. Forgetfulness; 2. Feeling tense or nervous; 3. Feeling 
blue or depressed; 4. Irritability or grouchiness; 5. Heart 
pounding or racing 
 
The Women’s Health at 
Midlife National Study 
(WHiMNS) (42) 
 
The revised Illness 
Perception Questionnaire  
A Menopause Specific 
Quality of Life questionnaire. 
 
How bothered they were on a 
4 point scale in the last 6 
months of the following 
symptoms 
1. Irritability/moods; 2. Memory loss 
 
Women’s International Study 




of Life Questionnaire 
 
Whether they had 
experienced the symptom in 
the previous month on a 7 
points Likert-Scale 
 
1. Dissatisfied with personal life; 2. Anxious or nervous; 3. 
Depressed; 4. Impatient with other people; 5. Wanting to be 
alone; 6. Feeling tired or worn out; 7. Mood swings 
 
 Table 2: Frequencies (yes/no) of various psychological symptoms (%), and mean values for psychological factor scores 































































































































































































































































Feeling Tense or nervous b 56++ 67 69++ 42 62 59 25++ 10  46         60 39 34 56   
Difficulty in sleepingc 65++ 53 52++ 31 48 60 48++ 36 67++ 56 61 41        
Excitable 45 49                  
Attack of panic 27+ 33               
Difficulty in concentratingd 59 61 43++ 18 34 38 29++ 14 43++ 32 31 22        
Feeling tired or lacking in energy 82 85 79++ 61 42 46 51++ 37 62+++ 69 70 36        
Loss of interest in most things 33++ 53                  
Feeling unhappy/ blue or depressed 47++ 53 41++ 28 26 32 40++ 18 45+ 38 42 27 41 52 32 22 40   
Crying spellse 28++ 22 83++ 62 67 68   34++ 29 25 15        
Irritability 55+ 61     37+ 28   51 44 43 40 56   
Anxiety   58++ 44 26 38   49+ 43 36 33        
Memory loss   54++ 34 46 46              
Mood swings/mood changes       31++ 15 54++ 54 50 32        
Forgetfulness         67++ 58 53 46        
Heart beating quickly or strongly 35++ 42 47++ 34 29 29 12+ 7            
CES-D Depression Scale Score             31++ 46 5 12 6 16++ 13 
The Zung Anxiety Scale Score               35+ 33 
The Perceived Stress Scale Score
(median IQR)f 
            8 11 8 9 8 21 20 
Psychological factor score Greene 
Climacteric Scale (GCS) 
6.66 7.05                  
Anxiety (GCS) 3.62 3.66                  
Depression (GCS) 3.10+ 3.40                  
Daily Symptoms Report (DSR) 
Psychological Scale Score 
                 52 50.0 
aNumbers computed into yes/no frequencies from Anderson et al. (2004), but significance is across 4 categories of not at all, a little, quite a bit, and extremely 
bAsked as “nervous tension” in HWHS and as “anxiety, tension, on edge, nerves” in POAS 
cAsked as “trouble sleeping difficulty in concentrating” in HWHS and “poor sleep” and “insomnia (trouble sleeping) in POAS 
dAsked as “combined with trouble sleeping” in HWHS, “combined with memory” in MAHWIS 
eAsked as “emotional” in DAMeS 
f IQR. Interquartile range 
+significant p<0.05 ; ++ significant p<0.01; +++significant p<0.001 / Palpitations, fatigue, and dizziness are included in both psychological and somatic reviews.  
Comment [M1]: Alphabetize in tables? 
Comment [a2]: We do not seem to be 
able to do this without destroying the table 
…let me know if it is absolutely vital and 
we will have to redo the whole table 
Table 3: Factors significant in multivariate models of psychological symptoms 
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a Mental Scale combined shortness of breath, sleeping problems and memory problems 
 
Variables entered into models 
b cultural group, age, education, family status, menopausal status, healthy lifestyle, ever use of HRT, chronic 
morbidity, BMI, Levels of depressive symptoms 
 
c site, baseline age, overall health, smoker, status, ethnicity, years since baseline, baseline paying for basics, hot 
flashes/night sweats, attitudes, psychotropic medication, social support, very stressful life events 
 
d menopausal status, race/ethnicity, age, education, self-assessed health, economic strain (tense, depressed, irritable 
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